Sandoz/NNP AG/NNP ,/, a/DT major/JJ Swiss/NNP chemical/NN and/CC pharmaceutical/JJ group/NN ,/, said/VBD that/DT its/PRP$ group/NN sales/NNS rose/VBD 25/CD %/NN to/TO 9.482/CD billion/CD francs/NNS -LRB-/-LRB- $/$ 5.80/CD billion/CD *U*/-NONE- -RRB-/-RRB- in/IN the/DT first/JJ nine/CD months/NNS of/IN this/DT year/NN ,/, with/IN strong/JJ gains/NNS in/IN all/DT divisions/NNS ./.
A/DT year/NN earlier/JJR sales/NNS totaled/VBD 7.567/CD billion/CD francs/NNS ./.
Positive/JJ currency/NN rates/NNS and/CC strong/JJ sales/NNS growth/NN led/VBD to/TO a/DT substantial/JJ rise/NN in/IN consolidated/JJ profit/NN in/IN the/DT period/NN ,/, although/IN the/DT company/NN did/VBD n't/RB provide/VB figures/NNS ,/, 0/-NONE- as/IN *T*-1/-NONE- is/VBZ customary/JJ with/IN Swiss/NNP companies/NNS ./.
Sandoz/NNP said/VBD 0/-NONE- it/PRP expects/VBZ a/DT ``/`` substantial/JJ increase/NN ''/'' in/IN consolidated/JJ profit/NN for/IN the/DT full/JJ year/NN ,/, */-NONE- barring/VBG major/JJ currency/NN rate/NN changes/NNS ./.

